zilovertamab (UC-961) - Ho’ola Therapeutics
eprenetapopt (APR-246) - Aprea
https://www.iwcll2025.org/fsPopup.asp?efp=UkpWR0RaQ0YyNDU0NA&PosterID=746309&rnd=5.350453E-02&mode=posterInfo
 
Emanuela M. Ghia, PhD; Can Huang, PhD; Michael Y. Choi, MD; George F. Widhopf II, PhD; Thomas J. Kipps, MD, PhD
 
Aug 8, 2025
 
Next